BlackRock’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$207M Buy
12,115,222
+2,208,354
+22% +$37.8M ﹤0.01% 1596
2025
Q1
$632M Sell
9,906,868
-1,285,118
-11% -$82M 0.01% 872
2024
Q4
$1.36B Buy
11,191,986
+168,672
+2% +$20.5M 0.03% 515
2024
Q3
$1.38B Buy
11,023,314
+698,910
+7% +$87.3M 0.03% 502
2024
Q2
$1.63B Buy
10,324,404
+4,364,034
+73% +$690M 0.04% 414
2024
Q1
$772M Sell
5,960,370
-251,422
-4% -$32.5M 0.02% 743
2023
Q4
$599M Buy
6,211,792
+178,057
+3% +$17.2M 0.02% 864
2023
Q3
$731M Buy
6,033,735
+530,269
+10% +$64.3M 0.02% 676
2023
Q2
$630M Buy
5,503,466
+220,771
+4% +$25.3M 0.02% 782
2023
Q1
$728M Sell
5,282,695
-199,471
-4% -$27.5M 0.02% 671
2022
Q4
$710M Buy
5,482,166
+144,862
+3% +$18.8M 0.02% 675
2022
Q3
$590M Sell
5,337,304
-270,359
-5% -$29.9M 0.02% 725
2022
Q2
$420M Buy
5,607,663
+60,704
+1% +$4.55M 0.01% 965
2022
Q1
$433M Buy
5,546,959
+261,725
+5% +$20.4M 0.01% 1083
2021
Q4
$476M Buy
5,285,234
+525,016
+11% +$47.3M 0.01% 1066
2021
Q3
$440M Sell
4,760,218
-106,133
-2% -$9.82M 0.01% 1079
2021
Q2
$378M Sell
4,866,351
-647,199
-12% -$50.3M 0.01% 1258
2021
Q1
$411M Buy
5,513,550
+134,335
+2% +$10M 0.01% 1176
2020
Q4
$917M Sell
5,379,215
-76,376
-1% -$13M 0.03% 562
2020
Q3
$766M Buy
5,455,591
+83,856
+2% +$11.8M 0.03% 562
2020
Q2
$861M Buy
5,371,735
+484,291
+10% +$77.7M 0.03% 474
2020
Q1
$478M Buy
4,887,444
+247,159
+5% +$24.2M 0.02% 625
2019
Q4
$599M Buy
4,640,285
+134,544
+3% +$17.4M 0.02% 690
2019
Q3
$339M Buy
4,505,741
+583,198
+15% +$43.9M 0.01% 1025
2019
Q2
$596M Sell
3,922,543
-264,721
-6% -$40.2M 0.03% 653
2019
Q1
$499M Sell
4,187,264
-657,967
-14% -$78.4M 0.02% 730
2018
Q4
$529M Buy
4,845,231
+36,972
+0.8% +$4.03M 0.03% 620
2018
Q3
$777M Buy
4,808,259
+121,003
+3% +$19.5M 0.03% 517
2018
Q2
$620M Sell
4,687,256
-1,374,153
-23% -$182M 0.03% 599
2018
Q1
$449M Sell
6,061,409
-224,934
-4% -$16.7M 0.02% 769
2017
Q4
$350M Buy
6,286,343
+58,433
+0.9% +$3.25M 0.02% 947
2017
Q3
$282M Buy
6,227,910
+1,008,468
+19% +$45.7M 0.01% 1068
2017
Q2
$176M Sell
5,219,442
-73,287
-1% -$2.47M 0.01% 1403
2017
Q1
$157M Buy
5,292,729
+5,175,193
+4,403% +$153M 0.01% 1463
2016
Q4
$3.22M Buy
117,536
+8,256
+8% +$226K ﹤0.01% 1045
2016
Q3
$6.71M Buy
109,280
+91,084
+501% +$5.59M 0.01% 832
2016
Q2
$347K Buy
18,196
+15,160
+499% +$289K ﹤0.01% 1790
2016
Q1
$60K Buy
3,036
+1,673
+123% +$33.1K ﹤0.01% 2222
2015
Q4
$53K Sell
1,363
-27,370
-95% -$1.06M ﹤0.01% 1987
2015
Q3
$923K Buy
28,733
+27,649
+2,551% +$888K ﹤0.01% 1300
2015
Q2
$33K Sell
1,084
-112
-9% -$3.41K ﹤0.01% 2119
2015
Q1
$16K Hold
1,196
﹤0.01% 2435
2014
Q4
$17K Hold
1,196
﹤0.01% 2426
2014
Q3
$25K Hold
1,196
﹤0.01% 2186
2014
Q2
$36K Sell
1,196
-2
-0.2% -$60 ﹤0.01% 2039
2014
Q1
$29K Buy
1,198
+64
+6% +$1.55K ﹤0.01% 2152
2013
Q4
$23K Buy
1,134
+96
+9% +$1.95K ﹤0.01% 2263
2013
Q3
$49K Hold
1,038
﹤0.01% 1830
2013
Q2
$40K Buy
+1,038
New +$40K ﹤0.01% 1941